Takeda Options Potential Iclusig Successor In Ascentage Deal

 
• By Dexter Jie Yan
  
succession
Takeda and Ascentage's option and share investment deals hinge on a potential successor to Iclusig. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia